Amino Acid Therapy for Hot Flashes in Postmenopausal Women

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the safety, tolerability, and effectiveness of the amino acid L-isoleucine in the treatment of hot flashes in postmenopausal women.

Clinical Trial Description

Hot flashes affect approximately 75% of postmenopausal women. Although hormone replacement therapy (HRT) is highly effective in reducing hot flashes, long-term HRT is associated with increased rates of breast cancer and heart disease. Safe, effective, and well-tolerated hot flash therapies are needed. The amino acids L-methionine and L-isoleucine have produced reductions in hot flash frequency. However, long-term L-methionine therapy may increase cardiovascular risks. This study will evaluate the short-term effects of L-isoleucine therapy. Data from this study will be used to conduct long-term studies in the future.

Participants in this study will be randomly assigned to receive one of two different L-isoleucine doses for 2 weeks. Clinic visits will be made at baseline, Week 1, and Week 10. Participants will record the frequency and severity of their hot flashes in a diary. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment

Related Conditions & MeSH terms

Hot Flashes

Clinical Trial Details

NCT number	NCT00081952
Study type	Interventional
Source	National Center for Complementary and Integrative Health (NCCIH)
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	October 2003
Completion date	October 2007

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04587154` - Womens Study to Alleviate Vasomotor Symptoms	N/A
Terminated	`NCT03642119` - Validation of an Objective Instrument to Measure Hot Flashes During Menopause
Completed	`NCT05061563` - A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults	Phase 1
Completed	`NCT05419908` - Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes	Phase 2
Completed	`NCT01281332` - Mechanical Device for the Relief of Hot Flashes	Phase 2
Completed	`NCT01439945` - Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer	Phase 2
Completed	`NCT00755417` - Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women	Phase 3
Completed	`NCT01293695` - Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial	N/A
Completed	`NCT00599456` - Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.	N/A
Completed	`NCT00256685` - Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause	Phase 3
Completed	`NCT00391417` - Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms	Phase 3
Terminated	`NCT00244894` - Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer	N/A
Completed	`NCT00010712` - Effects of Black Cohosh on Menopausal Hot Flashes	Phase 2
Recruiting	`NCT03580499` - Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy	N/A
Recruiting	`NCT06030388` - Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women	N/A
Recruiting	`NCT04418115` - Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?	N/A
Recruiting	`NCT04861701` - Effect and Predictors for Hot Flush in Women Undergoing Static Stretching Exercise	N/A
Active, not recruiting	`NCT05086705` - EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer	N/A
Completed	`NCT05099159` - A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)	Phase 3
Completed	`NCT01140646` - Evaluation of SAMe for Hot Flashes	Phase 2